An innovative chapter is quickly evolving around the possibility of exploiting epigenetic, microbial flora and hormones for the prevention and treatment of obesity and metabolic disorders.
There are no accepted guidelines as research is still in progress, but the need for a personalized and innovative approach to patients is becoming more and more essential.